Schedule 13G ownership disclosure

Amicus Therapeutics Inc

Common Stock · CUSIP: 03152W109

Event date: 2024-12-31

Filing-level shares
27,904,336
Percent of class
9.3%
  • BlackRock, Inc.

    Shares: 27,904,336 · Class: 9.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002012383-25-001182
Form type
SCHEDULE 13G/A
Filer
AMICUS THERAPEUTICS, INC.
CIK
CIK 1178879
Filed
Feb 05, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub